Jubilant Therapeutics and OneThree Biotech Collaborate to Advance Precision Oncology |
| November 12, 2020 | November 2020 Bond Updates |
|
BEDMINSTER, N.J. and NEW YORK, Nov. 12, 2020 /PRNewswire/ -- Jubilant Therapeutics Inc. ('Jubilant'), a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, and OneThree Biotech, a company redesigning drug... |
| View more at: https://www.prnewswire.com:443/news-releases/jubilant-therapeutics-and-onethree-biotech-collaborate-to-advance-precision-oncology-301171578.html |
| Related News |